199 related articles for article (PubMed ID: 32801296)
21. [Allo-HSCT for acute myeloid leukemia with myelodysplastic-related changes: a clinical analysis].
Zhang HX; Pang AM; Chen X; Zhang RL; Zhai WH; Ma QL; Yang DL; Wei JL; He Y; Feng SZ; Han MZ; Jiang EL
Zhonghua Xue Ye Xue Za Zhi; 2021 Oct; 42(10):814-822. PubMed ID: 34788920
[No Abstract] [Full Text] [Related]
22. Age-related inflammatory bone marrow microenvironment induces ineffective erythropoiesis mimicking del(5q) MDS.
Mei Y; Zhao B; Basiorka AA; Yang J; Cao L; Zhang J; List A; Ji P
Leukemia; 2018 Apr; 32(4):1023-1033. PubMed ID: 29263441
[TBL] [Abstract][Full Text] [Related]
23. SF3B1-mutated myelodysplastic syndrome with ring sideroblasts harbors more severe iron overload and corresponding over-erythropoiesis.
Zhu Y; Li X; Chang C; Xu F; He Q; Guo J; Tao Y; Liu Y; Liu L; Shi W
Leuk Res; 2016 May; 44():8-16. PubMed ID: 26970172
[TBL] [Abstract][Full Text] [Related]
24. Impaired Mitophagy of Nucleated Erythroid Cells Leads to Anemia in Patients with Myelodysplastic Syndromes.
Jiang H; Yang L; Guo L; Cui N; Zhang G; Liu C; Xing L; Shao Z; Wang H
Oxid Med Cell Longev; 2018; 2018():6328051. PubMed ID: 29967662
[TBL] [Abstract][Full Text] [Related]
25. Limited numbers of apoptotic cells in fresh paraffin embedded bone marrow samples of patients with myelodysplastic syndrome.
Brada SJ; van de Loosdrecht AA; Koudstaal J; de Wolf JT; Vellenga E
Leuk Res; 2004 Sep; 28(9):921-5. PubMed ID: 15234568
[TBL] [Abstract][Full Text] [Related]
26. The soluble transferrin receptor in dysplastic erythropoiesis in myelodysplastic syndrome.
Metzgeroth G; Rosée PL; Kuhn C; Schultheis B; Dorn-Beineke A; Hehlmann R; Hastka J
Eur J Haematol; 2007 Jul; 79(1):8-16. PubMed ID: 17532764
[TBL] [Abstract][Full Text] [Related]
27. Non-transferrin-bound iron in myelodysplastic syndromes: a marker of ineffective erythropoiesis?
Cortelezzi A; Cattaneo C; Cristiani S; Duca L; Sarina B; Deliliers GL; Fiorelli G; Cappellini MD
Hematol J; 2000; 1(3):153-8. PubMed ID: 11920184
[TBL] [Abstract][Full Text] [Related]
28. [Impact of induced therapy before allogeneic hematopoietic stem-cell transplantation for higher-risk myelodysplastic syndrome: experience of single centre].
Zhou JY; He GS; Wu DP; Sun AN; Qiu HY; Jin ZM; Tang XW; Han Y; Fu ZZ; Ma X; Miao M; Xue SL; Wang Y
Zhonghua Yi Xue Za Zhi; 2013 Oct; 93(40):3185-8. PubMed ID: 24405537
[TBL] [Abstract][Full Text] [Related]
29. Moderate to Severe Marrow Fibrosis As a More Advanced Risk Factor for MDS and MDS-AML Patients With Excess of Blasts Receiving Allogeneic Hematopoietic Stem Cell Transplantation.
Wang J; Wang Q; Zhang H; He Y; Huang Y; Zhang R; Wei J; Ma Q; Pang A; Yang D; Chen X; Jiang E; Feng S; Zhai W; Han M
Transplant Cell Ther; 2021 Aug; 27(8):666.e1-666.e9. PubMed ID: 34020086
[TBL] [Abstract][Full Text] [Related]
30. Exploring dyserythropoiesis in patients with myelodysplastic syndrome by imaging flow cytometry and machine-learning assisted morphometrics.
Rosenberg CA; Bill M; Rodrigues MA; Hauerslev M; Kerndrup GB; Hokland P; Ludvigsen M
Cytometry B Clin Cytom; 2021 Sep; 100(5):554-567. PubMed ID: 33285035
[TBL] [Abstract][Full Text] [Related]
31. APG101 efficiently rescues erythropoiesis in lower risk myelodysplastic syndromes with severe impairment of hematopoiesis.
Raimbault A; Pierre-Eugene C; Rouquette A; Deudon C; Willems L; Chapuis N; Mathis S; Kunz C; Fricke H; Kosmider O; Bardet V; Fontenay M;
Oncotarget; 2016 Mar; 7(12):14898-911. PubMed ID: 26910909
[TBL] [Abstract][Full Text] [Related]
32. Severely impaired terminal erythroid differentiation as an independent prognostic marker in myelodysplastic syndromes.
Ali AM; Huang Y; Pinheiro RF; Xue F; Hu J; Iverson N; Hoehn D; Coutinho D; Kayani J; Chernak B; Lane J; Hillyer C; Galili N; Jurcic J; Mohandas N; An X; Raza A
Blood Adv; 2018 Jun; 2(12):1393-1402. PubMed ID: 29903708
[TBL] [Abstract][Full Text] [Related]
33. Association of red cell distribution width with clinical outcomes in myelodysplastic syndrome.
Baba Y; Saito B; Shimada S; Sasaki Y; Murai S; Abe M; Fujiwara S; Arai N; Kawaguchi Y; Kabasawa N; Tsukamoto H; Uto Y; Ariizumi H; Yanagisawa K; Hattori N; Harada H; Nakamaki T
Leuk Res; 2018 Apr; 67():56-59. PubMed ID: 29433052
[TBL] [Abstract][Full Text] [Related]
34. A Randomized Study Comparing Stem Cell Transplantation Versus Conventional Therapy for Low- and Intermediate-Risk Myelodysplastic Syndromes Patients.
Yu ZP; Ding JH; Sun AN; Ge Z; Chen BA; Wu DP
Stem Cells Dev; 2017 Aug; 26(15):1132-1139. PubMed ID: 28494646
[TBL] [Abstract][Full Text] [Related]
35. High erythroferrone expression in CD71
Riabov V; Mossner M; Stöhr A; Jann JC; Streuer A; Schmitt N; Knaflic A; Nowak V; Weimer N; Obländer J; Palme I; Schumann C; Baldus CD; Schulze TJ; Wuchter P; Röhl H; Jawhar A; Weiss C; Boch T; Metzgeroth G; Neumann M; Hofmann WK; Nolte F; Nowak D
Br J Haematol; 2021 Mar; 192(5):879-891. PubMed ID: 33486765
[TBL] [Abstract][Full Text] [Related]
36. Impaired formation of erythroblastic islands is associated with erythroid failure and poor prognosis in a significant proportion of patients with myelodysplastic syndromes.
Buesche G; Teoman H; Giagounidis A; Göhring G; Schlegelberger B; Ganser A; Aul C; Kreipe HH
Haematologica; 2016 May; 101(5):e177-81. PubMed ID: 26944473
[No Abstract] [Full Text] [Related]
37. Nuclear translocation of PKC-α is associated with cell cycle arrest and erythroid differentiation in myelodysplastic syndromes (MDSs).
Poli A; Ratti S; Finelli C; Mongiorgi S; Clissa C; Lonetti A; Cappellini A; Catozzi A; Barraco M; Suh PG; Manzoli L; McCubrey JA; Cocco L; Follo MY
FASEB J; 2018 Feb; 32(2):681-692. PubMed ID: 28970249
[TBL] [Abstract][Full Text] [Related]
38. H2AX deficiency is associated with erythroid dysplasia and compromised haematopoietic stem cell function.
Zhao B; Tan TL; Mei Y; Yang J; Yu Y; Verma A; Liang Y; Gao J; Ji P
Sci Rep; 2016 Jan; 6():19589. PubMed ID: 26791933
[TBL] [Abstract][Full Text] [Related]
39. Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic Syndromes.
Arenillas L; Calvo X; Luño E; Senent L; Alonso E; Ramos F; Ardanaz MT; Pedro C; Tormo M; Marco V; Montoro J; Díez-Campelo M; Brunet S; Arrizabalaga B; Xicoy B; Andreu R; Bonanad S; Jerez A; Nomdedeu B; Ferrer A; Sanz GF; Florensa L
J Clin Oncol; 2016 Sep; 34(27):3284-92. PubMed ID: 27382099
[TBL] [Abstract][Full Text] [Related]
40. Significance of fetal hemoglobin-containing erythroblasts (F blasts) and the F blast/F cell ratio in myelodysplastic syndromes.
Choi JW; Kim Y; Fujino M; Ito M
Leukemia; 2002 Aug; 16(8):1478-83. PubMed ID: 12145688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
